id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4693-0001,FDA,FDA-2019-N-4693,"Mayne Pharma Group Limited and Actavis Laboratories UT, Inc.; Withdrawal of Approval of Abbreviated New Drug Applications for Fentanyl Transdermal Systems",Notice,Withdrawal,2019-11-18T05:00:00Z,2019,11,2019-11-18T05:00:00Z,,2019-11-18T14:23:03Z,2019-24922,0,0,09000064841714e0